Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 390

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 390
---
. For Rewell’s expansion, this requires engaging nutrigeneticists from each specific country to tailor health guidance effectively to each customer’s unique needs within their geographic context. These nutrigeneticists will assist in the development of AI Agents catered to each specific geography. Regarding the integration of AI Agents into our telemedicine services, it is important to note that AI -specificregulations in these countries are still evolving. In Argentina, legislative proposals were introduced in 2023 aiming to regulate AI technologies, focusing on ethical and responsible use, with an emphasis on protecting human rights and privacy. As of now, these initiatives have not been enacted into law. Similarly, Mexico and Paraguay have yet to implement comprehensive AI policies, though discussions are ongoing. In the absence of specific AI regulations, our approach is to comply with existing healthcare and data protection laws in each country. We ensure that all AI -drivenservices are supervised by certified medical professionals authorized to operate within the telemedicine industry in their respective countries. This includes maintaining high standards of patient confidentiality, data security, and informed consent. We are committed to monitoring regulatory developments related to AI and telemedicine in all operating countries and will adapt our practices to ensure ongoing compliance with any new laws or guidelines. Biological Sample Logistics and Data Transfer The collection, transport, and analysis of biological samples, as well as the cross -bordertransfer of biological data, must comply with each country’s regulations to protect patient safety and ensure data privacy. In Argentina, biological sample transport adheres to national and international safety standards, and data transfer is governed by the Personal Data Protection Law to ensure confidentiality. In Mexico, the General Health Law governs biological sample handling, while the Federal Law on the Protection of Personal Data governs data transfer. In Paraguay, similar general health regulations apply to the safe handling and confidentiality of biological samples and data, with laboratories required to follow standardized protocols for privacy and safety. Cross -bordertransfer of biological samples and data is generally permitted in Latin America, including Argentina, Mexico, and Paraguay, provided that such transfers comply with the respective national regulations and international agreements. This requires obtaining necessary permits, adhering to biosafety standards, and implementing robust data protection measures. Laboratories within our consortium are required to meet these standards as a condition for distributing our products and services. They must have the appropriate permits, biosafety protocols, and data protection measures in place to ensure regulatory compliance. OmnigenicsAI, in turn, adheres to biosafety standards, and enforces comprehensive data protection